- R&D
New York University Study Finds Prominent Breakthrough for Pain Management; Outperforms Pain Drug
Researchers at New York University have made an important discovery in the field of pain management, revealing a potential paradigm shift. Their...EnginZyme Utilizes Biocatalysis to Manufacture Essential Component for mRNA Vaccines
Mohsin Riaz - 0EnginZyme AB, a cutting-edge technology company specializing in enzymatic biomanufacturing, has successfully patented a revolutionary process for producing pseudouridine, a critical component...Labcorp Unveils Breakthrough Blood Test for Alzheimer’s Diagnosis and Neurodegenerative Disease Detection
Labcorp has introduced a novel blood test aimed at aiding the diagnosis of Alzheimer's disease, further enhancing its range of services in...Overcoming Age-Related Challenges in Nanodrug Delivery for Pediatric Cancer Patients
The efficacy of medical treatments often varies with age, and this principle holds true in the world of nanodrug delivery for pediatric,...
- Clinical
Setback for Bayer as Promising Anti-Clotting Drug Trials Halted
In a significant setback for Germany's pharmaceutical giant Bayer, the company has halted a large late-stage trial testing its highly anticipated anti-clotting...Karuna Therapeutics Phase 1b Trial Results Reinforce Cardiovascular Safety of Schizophrenia Treatment KarXT
The Phase 1b unrestricted-label, eight-week residential trial meant to assess the influence of KarXT (xanomeline-trospium) on round-the-clock ambulatory blood pressure in adults...Novo Says Weight Loss Alone Isn’t to Thank For Wegovy’s Heart Benefits
Novo Nordisk unveiled fresh findings at a prominent medical conference, indicating that the cardiovascular benefits of its widely used Wegovy obesity treatment...AstraZeneca Looking For Another Liver Cancer Green Light For Imfinzi
After last year's nod, AstraZeneca's flagship PD-L1 Imfinzi is demonstrating efficacy in another group suffering from hepatocellular carcinoma (HCC), the type of...
- Manufacturing
Lilly plans to construct a $2.5 billion manufacturing facility in Germany
Eli Lilly, a U.S.-based pharmaceutical company, has announced plans to construct its first manufacturing facility in Germany, specifically in the town of...Merck and Ginkgo Forge $490 Million Partnership to Enhance Biologics Manufacturing Efficiency
Merck has solidified a substantial collaboration valued at $490 million with Ginkgo Bioworks, aimed at revolutionizing the landscape of biologics manufacturing. This...Vertex and Lonza Join Forces to Open New Manufacturing Facility for the Former’s T1D Therapies
Vertex Pharmaceuticals and Lonza have announced a strategic partnership to construct a new joint manufacturing facility in Portsmouth, New Hampshire. The primary...Pfizer to Stop Development of Oral Obesity Drug Amidst Liver Safety Concerns
Pfizer is set to discontinue one of its oral obesity drugs - namely lotiglipron - after observing higher levels of liver enzymes...
- Commercial
Novo Nordisk Set to Slash Victoza Production to Boost Ozempic Supply
In response to the escalating demand for its GLP-1 weight loss products, Novo Nordisk is adopting a new approach. The company is...Merck to Purchase Caraway Therapeutics For Over $600M
Merck & Co. has openly expressed its continuous pursuit of acquisitions, and currently, the prominent pharmaceutical company is concluding the year by...NanoString Faces Setback in Patent Infringement Case Against Genomics
In a recent legal skirmish in the biotechnology sector, NanoString finds itself on the losing end of a federal jury decision against...
- Technology
Siemens Healthineers & Qure.ai partnership Aims to Enhance Tuberculosis Diagnosis Using AI
Siemens Healthineers, in collaboration with Qure.ai and the Global Fund to Combat AIDS, Tuberculosis, and Malaria, is spearheading an initiative to expedite...Philips Launches New Platform to Improve Health Monitoring
Over two years following the acquisition of the medical information aggregator Capsule Technologies, Philips is introducing an innovative integrated information platform. This...Zeiss and Boehringer Ingelheim have formed an AI-backed alliance
A recently established collaboration between Zeiss Medical Technology and Boehringer Ingelheim is laser-focused on the early detection and targeted treatment of retinal...Trialbee’s new tool aims to expedite clinical trial recruitment delays
Clinical trials play a pivotal role in advancing medical research and the development of innovative treatments. However, one major hurdle that often...
- Regulatory
FDA Expresses Doubt Over Merck’s Cough Candidate
Merck & Co. is racing against the clock to launch the first medication for chronic coughing on the market. With the FDA...After success with its BabySat system, Owlet gains FDA clearance for its Dream Sock
Owlet, the innovative baby monitoring system company, is celebrating a significant milestone as it secures FDA clearance for its Dream Sock technology....Federal Court Rejects Alvogen’s Bid for FDA Approval of Bausch’s Xifaxan Version
Salix Pharmaceuticals, a subsidiary of Bausch Health, has emerged victorious in its ongoing legal battle to protect its medication Xifaxan, used to...FDA Advisors Greenlight First CRISPR-Based Therapy with Confidence in Off-Target Tests
FDA advisers have expressed contentment with CRISPR Therapeutics and Vertex Pharmaceuticals' comprehensive evaluation of potential off-target effects in their CRISPR-based gene therapy,...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
- R&D
New York University Study Finds Prominent Breakthrough for Pain Management; Outperforms Pain Drug
Researchers at New York University have made an important discovery in the field of pain management, revealing a potential paradigm shift. Their...EnginZyme Utilizes Biocatalysis to Manufacture Essential Component for mRNA Vaccines
Mohsin Riaz - 0EnginZyme AB, a cutting-edge technology company specializing in enzymatic biomanufacturing, has successfully patented a revolutionary process for producing pseudouridine, a critical component...Labcorp Unveils Breakthrough Blood Test for Alzheimer’s Diagnosis and Neurodegenerative Disease Detection
Labcorp has introduced a novel blood test aimed at aiding the diagnosis of Alzheimer's disease, further enhancing its range of services in...Overcoming Age-Related Challenges in Nanodrug Delivery for Pediatric Cancer Patients
The efficacy of medical treatments often varies with age, and this principle holds true in the world of nanodrug delivery for pediatric,...
- Clinical
Setback for Bayer as Promising Anti-Clotting Drug Trials Halted
In a significant setback for Germany's pharmaceutical giant Bayer, the company has halted a large late-stage trial testing its highly anticipated anti-clotting...Karuna Therapeutics Phase 1b Trial Results Reinforce Cardiovascular Safety of Schizophrenia Treatment KarXT
The Phase 1b unrestricted-label, eight-week residential trial meant to assess the influence of KarXT (xanomeline-trospium) on round-the-clock ambulatory blood pressure in adults...Novo Says Weight Loss Alone Isn’t to Thank For Wegovy’s Heart Benefits
Novo Nordisk unveiled fresh findings at a prominent medical conference, indicating that the cardiovascular benefits of its widely used Wegovy obesity treatment...AstraZeneca Looking For Another Liver Cancer Green Light For Imfinzi
After last year's nod, AstraZeneca's flagship PD-L1 Imfinzi is demonstrating efficacy in another group suffering from hepatocellular carcinoma (HCC), the type of...
- Manufacturing
Lilly plans to construct a $2.5 billion manufacturing facility in Germany
Eli Lilly, a U.S.-based pharmaceutical company, has announced plans to construct its first manufacturing facility in Germany, specifically in the town of...Merck and Ginkgo Forge $490 Million Partnership to Enhance Biologics Manufacturing Efficiency
Merck has solidified a substantial collaboration valued at $490 million with Ginkgo Bioworks, aimed at revolutionizing the landscape of biologics manufacturing. This...Vertex and Lonza Join Forces to Open New Manufacturing Facility for the Former’s T1D Therapies
Vertex Pharmaceuticals and Lonza have announced a strategic partnership to construct a new joint manufacturing facility in Portsmouth, New Hampshire. The primary...Pfizer to Stop Development of Oral Obesity Drug Amidst Liver Safety Concerns
Pfizer is set to discontinue one of its oral obesity drugs - namely lotiglipron - after observing higher levels of liver enzymes...
- Commercial
Novo Nordisk Set to Slash Victoza Production to Boost Ozempic Supply
In response to the escalating demand for its GLP-1 weight loss products, Novo Nordisk is adopting a new approach. The company is...Merck to Purchase Caraway Therapeutics For Over $600M
Merck & Co. has openly expressed its continuous pursuit of acquisitions, and currently, the prominent pharmaceutical company is concluding the year by...NanoString Faces Setback in Patent Infringement Case Against Genomics
In a recent legal skirmish in the biotechnology sector, NanoString finds itself on the losing end of a federal jury decision against...
- Technology
Siemens Healthineers & Qure.ai partnership Aims to Enhance Tuberculosis Diagnosis Using AI
Siemens Healthineers, in collaboration with Qure.ai and the Global Fund to Combat AIDS, Tuberculosis, and Malaria, is spearheading an initiative to expedite...Philips Launches New Platform to Improve Health Monitoring
Over two years following the acquisition of the medical information aggregator Capsule Technologies, Philips is introducing an innovative integrated information platform. This...Zeiss and Boehringer Ingelheim have formed an AI-backed alliance
A recently established collaboration between Zeiss Medical Technology and Boehringer Ingelheim is laser-focused on the early detection and targeted treatment of retinal...Trialbee’s new tool aims to expedite clinical trial recruitment delays
Clinical trials play a pivotal role in advancing medical research and the development of innovative treatments. However, one major hurdle that often...
- Regulatory
FDA Expresses Doubt Over Merck’s Cough Candidate
Merck & Co. is racing against the clock to launch the first medication for chronic coughing on the market. With the FDA...After success with its BabySat system, Owlet gains FDA clearance for its Dream Sock
Owlet, the innovative baby monitoring system company, is celebrating a significant milestone as it secures FDA clearance for its Dream Sock technology....Federal Court Rejects Alvogen’s Bid for FDA Approval of Bausch’s Xifaxan Version
Salix Pharmaceuticals, a subsidiary of Bausch Health, has emerged victorious in its ongoing legal battle to protect its medication Xifaxan, used to...FDA Advisors Greenlight First CRISPR-Based Therapy with Confidence in Off-Target Tests
FDA advisers have expressed contentment with CRISPR Therapeutics and Vertex Pharmaceuticals' comprehensive evaluation of potential off-target effects in their CRISPR-based gene therapy,...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
Editor Picks
Novavax breaks production contract with Fujifilm, pays $185 Million
Following an FDA approval this summer, Novavax has experienced lower demand for...
Novartis subsidiary Sandoz increasing its antibiotics manufacturing capacity in Europe with $183m investment
Sandoz, a Novartis company , is planning to invest $183 million (€150 million) in Kundl, Spain, Austria, and Palafolls to expand its antibiotic production network in Europe.
United Health Group Acquires New York-Based Physician Group
NewYork-based healthcare company Crystal Run has been reportedly purchased by UnitedHealth Group....
Must Read
Novo Nordisk Set to Slash Victoza Production to Boost Ozempic Supply
In response to the escalating demand for its GLP-1 weight loss products,...
Merck to Purchase Caraway Therapeutics For Over $600M
Merck & Co. has openly expressed its continuous pursuit of acquisitions, and...
NanoString Faces Setback in Patent Infringement Case Against Genomics
In a recent legal skirmish in the biotechnology sector, NanoString finds itself...
About Us
Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.
Contact us: reachout(at)lifescivoice.com